IL-4 and IL-13 mediate a class switch to IgE production by B cells so that, with increased activity of these cytokines in the diseased tissue in asthma and CRSwNP, IgE antibodies are not an expression of allergy but also of generic type 2 activation. This evidence concerns the gene IL13 and chronic rhinosinusitis with nasal polyps.